@article{Jiang2026, 
author = {Zhuangzhuang Jiang and Yingwei Wu and Feng Cao and Jianghao Wang and Shuqing Ye and Yihang Sui and Ninghua Tan},
title = {Natural cyclopeptide RA-V induces ER stress and promotes HRD1-mediated c-Myc degradation to inhibit pancreatic cancer stemness},
year = {2026},
journal = {Chinese Journal of Natural Medicines},
volume = {24},
number = {12},
pages = {1522-1535},
keywords = {Pancreatic cancer, Natural cyclopeptide RA-V, c-Myc degradation, Regulation of stemness, Endoplasmic reticulum stress, HMG-CoA reductase degradation protein 1 (HRD1)},
url = {https://www.sciopen.com/article/10.1016/S1875-5364(26)61238-1},
doi = {10.1016/S1875-5364(26)61238-1},
abstract = {Pancreatic cancer (PC) is one of the most lethal malignancies, and current treatments rarely result in long-term survival. One of the key factors defining its resilience against chemotherapy is the existence of cancer stem cells. c-Myc is a highly amplified oncogene and one of the “most wanted” targets for cancer therapy and maintains tumor stemness, which has so far been an undruggable target. Herein, we describe that a natural cyclopeptide RA-V from Rubia yunnanensis induced ER stress, reduced c-Myc expression and tumor stemness in vitro and vivo. Mechanistically, RA-V induced ER stress-mediated apoptosis through activated the PERK/eIF2α/ATF4/CHOP pathway; RA-V targeted and stabilized the ubiquitin ligase HMG-CoA reductase degradation protein 1 (HRD1), thereby mediating ER-associated degradation (ERAD) of c-Myc protein and decreasing stemness of PC cells. This study provides not only a novel pharmacological strategy to modulate the expression of c-Myc protein, but also new insights into the antitumor mechanism of RA-V.}
}